More than half of a couple hundred patients who completed a new survey, 52%, ran into trouble when trying to see their medical images and reports or share same with their care team.

An AI startup has received the FDA’s go-ahead to market a new tool within its existing platform that automatically diagnoses stroke and brain injury in hyperdense brain tissue imaged with unenhanced CT.

Two weeks ago CMS proposed a 2023 physician fee schedule (PFS) that stands to slash pay to U.S. diagnostic radiologists by 3% and interventionalists by 4%. This week the U.K.’s National Health Service put that country’s radiologists in a similar bind.

Reviewing a 20-month run with a radiologist-to-technologist communications tool, researchers have found minor problems with image quality 10 times more common than patient callbacks for repeat imaging.

A Canadian manufacturer of positron emission tomography equipment has received FDA’s OK to market a small-footprint scanner that images targeted organs bearing radiotracers at close range.

A global tech and pharma vendor is set to inject U.S. healthcare with a set of generic contrast agents, the first of which will be an FDA-approved substitute for GE Healthcare’s Visipaque.

For years radiology educators have been reassuring prospects, recruits and trainees that artificial intelligence can only—and will only—assist or augment radiologists. And still a nervous concern continues to come up. 

American Medical Association President Gerald Harmon, MD, joined us for an exclusive chat about some of the hottest topics discussed at the 2022 AMA House of Delegates meeting.